|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-16
|
$320,126
|
$22,409
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Wnt Signaling and Secreted Frizzled-Related Proteins
|
ZIA BC 010251
|
$318,862
|
$63,772
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-23S1
|
$125,000
|
$1,250
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-23
|
$431,709
|
$4,317
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$2,192,713
|
$1,754,171
|
Linehan, W. Marston
|
CCR (NCI)
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-29
|
$2,114,386
|
$84,575
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$224,566
|
$44,913
|
Fowler, Daniel
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$336,277
|
$6,726
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$192,735
|
$90,586
|
Merino, Maria
|
CCR (NCI)
|
|
Tissue Processing/Sequencing Core
|
ZIC BC 011044
|
$404,912
|
$242,947
|
Vocke, Cathy
|
CCR (NCI)
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$527,328
|
$52,733
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Therapeutic use of immunomodulators and ionizining radiation
|
ZIA BC 011455
|
$113,412
|
$37,426
|
Haglund, Karl
|
CCR (NCI)
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$282,062
|
$56,412
|
Lewandoski, Mark
|
CCR (NCI)
|
|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
$40,133
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$591,988
|
$59,199
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Study of Hereditary Renal and Other Familial Syndromes
|
ZIA BC 010696
|
$192,735
|
$115,641
|
Merino, Maria
|
CCR (NCI)
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-27
|
$1,874,946
|
$18,749
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Signal Transduction Events and the Regulation of Cell Growth
|
ZIC SC 006743
|
$553,945
|
$83,092
|
Trepel, Jane
|
CCR (NCI)
|
|
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
|
ZIA SC 010074
|
$443,273
|
$177,309
|
Neckers, Leonard
|
CCR (NCI)
|
|
Role of FH loss in development of HLRCC heriditary kidney cancer
|
ZIA BC 010683
|
$221,636
|
$221,636
|
Neckers, Leonard
|
CCR (NCI)
|
|
Research Nursing
|
ZID BC 010950
|
$922,235
|
$46,112
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
Regulation of Ras-Dependent Signal Transduction Pathways
|
ZIA BC 010329
|
$394,899
|
$78,980
|
Morrison, Deborah
|
CCR (NCI)
|
|
Radiological Physics Center
|
5U10CA010953-45
|
$2,786,631
|
$27,866
|
Followill, David
|
UT MD ANDERSON CANCER CTR
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-37
|
$14,566,378
|
$145,664
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Queens Cancer Center Minority-Based Community Clinical Oncology Program
|
2U10CA149944-04
|
$465,669
|
$4,657
|
KEMENY, MARY
|
NEW YORK CITY HEALTH & HOSPITALS CORP
|
|
Quality Assurance Review Center
|
3U10CA029511-33S1
|
$1,946,959
|
$19,470
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Promoting tumor cell apoptosis by death ligands
|
ZIA BC 011056
|
$240,887
|
$120,443
|
Sayers, Thomas
|
CCR (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$485,878
|
$48,588
|
Figg, William
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$318,269
|
$111,394
|
Bottaro, Donald
|
CCR (NCI)
|
|
Northern Indiana Cancer Research Corsoortium, CCOP
|
2U10CA086726-14
|
$710,588
|
$7,106
|
Method, Michael
|
MEMORIAL HOSPITAL OF SOUTH BEND
|
|
North Shore CCOP
|
5U10CA035279-30
|
$711,448
|
$7,114
|
VINCIGUERRA, VINCENT
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA045564-26A1
|
$467,134
|
$4,671
|
SCHWARTZ, MICHAEL
|
MOUNT SINAI MEDICAL CENTER (MIAMI BEACH)
|
|
Molecularly targeted natural products discovery from diverse natural sources
|
ZIA BC 011467
|
$659,534
|
$131,907
|
Gustafson, Kirk
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,252,979
|
$939,734
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$1,252,979
|
$1,240,449
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$201,577
|
$201,577
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$1,229,426
|
$245,885
|
Edelman, Daniel
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$50,263
|
$25,131
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$787,813
|
$315,125
|
Hou, Steven
|
CCR (NCI)
|
|
Missouri Valley Cancer Consortium CCOP
|
5U10CA063849-20
|
$554,200
|
$5,542
|
Soori, Gamini
|
MISSOURI VALLEY CANCER CONSORTIUM, INC.
|
|
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
|
ZIA BC 010625
|
$325,103
|
$162,551
|
Fojo, Antonio
|
CCR (NCI)
|
|
microRNA Profiling in the Spectrum of Kidney Tumors
|
ZIA BC 011405
|
$128,490
|
$128,490
|
Merino, Maria
|
CCR (NCI)
|
|
Micro RNA Profiling in Pediatric Cancers
|
ZIA BC 011001
|
$115,824
|
$5,791
|
Khan, Javed
|
CCR (NCI)
|
|
Metabolic Mechanisms for Programmed Cell Death
|
ZIA BC 010743
|
$305,481
|
$122,192
|
Phang, James
|
CCR (NCI)
|
|
Membrane trafficking function in primary cilium assembly and signaling
|
ZIA BC 011398
|
$625,027
|
$437,519
|
Westlake, Christopher
|
CCR (NCI)
|
|
Meharry Medical College Minority-Based Community Clinical Oncology Program
|
5U10CA107612-10
|
$285,980
|
$2,860
|
Murray, John
|
MEHARRY MEDICAL COLLEGE
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,497,257
|
$449,726
|
Fojo, Antonio
|
CCR (NCI)
|
|
Medical Director's Office
|
ZID BC 010951
|
$2,426,933
|
$242,693
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
Mechanisms Used by NKT Cells in the Control of Liver Tumors
|
ZIA BC 009322
|
$287,493
|
$28,749
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$630,367
|
$31,518
|
Gottesman, Michael
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $17,558,503
|